---
title: "LXTG released its performance for the first three quarters, with a net profit attributable to the parent company of 60.9959 million yuan, a year-on-year decrease of 45.59%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263456602.md"
description: "According to the Zhitong Finance APP, LXTG released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 3.241 billion yuan, a year-on-year increase of 3.76%. The net profit attributable to shareholders of the listed company was 60.9959 million yuan, a year-on-year decrease of 45.59%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 56.2401 million yuan, a year-on-year decrease of 48.58%"
datetime: "2025-10-30T08:27:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263456602.md)
  - [en](https://longbridge.com/en/news/263456602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263456602.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263456602.md) | [English](https://longbridge.com/en/news/263456602.md)


# LXTG released its performance for the first three quarters, with a net profit attributable to the parent company of 60.9959 million yuan, a year-on-year decrease of 45.59%

According to the Zhitong Finance APP, LXTG (002442.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 3.241 billion yuan, a year-on-year increase of 3.76%. The net profit attributable to shareholders of the listed company was 60.9959 million yuan, a year-on-year decrease of 45.59%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 56.2401 million yuan, a year-on-year decrease of 48.58%

### 相關股票

- [LXTG (002442.CN)](https://longbridge.com/zh-HK/quote/002442.CN.md)

## 相關資訊與研究

- [China Shenhua Energy's February coal sales down 3.2% Y/Y](https://longbridge.com/zh-HK/news/279030290.md)
- [Paralympics-Broken kit, no problem: the Paralympics rapid‑repair lifeline](https://longbridge.com/zh-HK/news/279096386.md)
- [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/zh-HK/news/279052280.md)
- [A Look At Star Plus Legend Holdings’ Valuation As Guidance Swings From Profit To Loss](https://longbridge.com/zh-HK/news/279105880.md)
- [Volkswagen reclaims top spot in China car sales, BYD falls to fourth as EV subsidies fade](https://longbridge.com/zh-HK/news/279028881.md)